TAC-101

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAC-101, covering 2018-10-31 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma [Phase 2]

See pricing